BXP vs CUBE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BXP exhibits a stable but fragile financial health with a Piotroski F-Score of 4/9, while valuation metrics suggest the stock is significantly overpriced. The current price of $57.73 trades at a steep premium to the Graham Number ($35.65) and the Intrinsic Value ($12.18). Severe revenue contraction (-31.90% YoY) and an unsustainable dividend payout ratio of 193.10% indicate a high risk of capital erosion or dividend cuts. Despite bullish analyst targets, the deterministic data and bearish insider activity point toward a value trap.
CUBE exhibits significant valuation misalignment and deteriorating financial fundamentals. The deterministic baseline is weak, with a Piotroski F-Score of 4/9 (Stable/Weak) and a current price of $39.54 that vastly exceeds both the Graham Number ($19.83) and the Intrinsic Value ($10.22). Most concerning is the unsustainable dividend payout ratio of 143.15% coupled with a -21.70% YoY decline in earnings growth. With zero earnings beats in the last four quarters and bearish insider activity, the stock appears heavily overvalued.
Compare Another Pair
Related Comparisons
BXP vs CUBE: Head-to-Head Comparison
This page compares BXP, Inc. (BXP) and CubeSmart (CUBE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.